Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.40 |
| ▸ | TNFRSF1A | P19438 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | APP | P05067 | 5/20 | 0.38 |
| ▸ | GCGR | P47871 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2672765 | 0.94 | MAPT (0.41) | LMNAMAPTMAPK1ABCG2TNFRSF1A | |
| SCHEMBL867428 | 0.90 | LMNA (0.41) | LMNAMAPTMAPK1ABCG2TNFRSF1A | |
| SCHEMBL865593 | 0.89 | KMT2A (0.45) | LMNAMAPTABCG2TNFRSF1ACA1 | |
| SCHEMBL865531 | 0.89 | APP (0.37) | LMNAMAPTMAPK1CA1CA2 | |
| SCHEMBL865169 | 0.89 | APP (0.37) | LMNAMAPTMAPK1CA1CA2 | |
| SCHEMBL867335 | 0.88 | LMNA (0.39) | LMNAMAPTMAPK1ABCG2TNFRSF1A | |
| SCHEMBL865673 | 0.88 | LMNA (0.44) | LMNAMAPTMAPK1ABCG2TNFRSF1A | |
| SCHEMBL2671334 | 0.88 | LMNA (0.39) | LMNAMAPTMAPK1ABCG2TNFRSF1A | |
| SCHEMBL1564083 | 0.88 | LMNA (0.39) | LMNAMAPTMAPK1ABCG2TNFRSF1A | |
| SCHEMBL867313 | 0.84 | KDM4E (0.43) | LMNAMAPTABCG2TNFRSF1ACA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107438653-B | Photoalignment composition | 罗利克有限公司 | 2022-01-07 | — | — | CN | disclosed |
| CN-113652167-A | Photoalignment composition | 罗利克有限公司 | 2021-11-16 | — | — | CN | disclosed |
| US-10557085-B2 | Photoalignment composition | ROLIC AG (CH) | 2020-02-11 | — | — | US | disclosed |
| US-20180079961-A1 | PHOTOALIGNMENT COMPOSITION | ROLIC AG (CH) | 2018-03-22 | — | — | US | disclosed |
| US-20170362381-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | ROLIC AG (CH) | 2017-12-21 | — | — | US | disclosed |
| EP-1966119-B1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2016-10-19 | — | — | EP | disclosed |
| US-8329823-B2 | Photocrosslinkable materials | ROLIC AG (CH) | 2012-12-11 | — | — | US | disclosed |
| US-8173749-B2 | Photocrosslinkable materials | ROLIC AG (CH) | 2012-05-08 | — | — | US | disclosed |
| US-20120076952-A1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2012-03-29 | — | — | US | disclosed |
| EP-2308827-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2011-04-13 | — | — | EP | disclosed |
| EP-2305632-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2011-04-06 | — | — | EP | disclosed |
| EP-2305631-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2011-04-06 | — | — | EP | disclosed |
| US-20080293888-A1 | Photocrosslinkable Materials | ROLIC AG (CH) | 2008-11-27 | — | — | US | disclosed |
| EP-1975687-A1 | Method of uniform and defect free liquid crystal aligning layers | Rolic AG (CH) | 2008-10-01 | — | — | EP | disclosed |
| EP-1860094-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2007-11-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293888-A1 | Photocrosslinkable Materials | DDC, PARG, ALAD | LMNA 2057/4885MAPT 295/4885MAPK1 1276/4885 |
| US-20120076952-A1 | PHOTOCROSSLINKABLE MATERIALS | DDC, PARG, ALAD | LMNA 2057/4885MAPT 295/4885MAPK1 1276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.